QB3's VC Fund Raises $7.5M to Fund Startups | GenomeWeb

NEW YORK (GenomeWeb News) – The new venture capital firm created by the California Institute for Quantitative Biosciences, or QB3, is in "due diligence" review phases of selecting its first of 15 startups set to receive portions of a recently raised $7.5 million seed money fund.

Mission Bay Capital LLC is "expecting to make two to four investments a year over the next three or four years," Douglas Crawford, QB3's director of industry alliances and associate executive director, told GenomeWeb Daily News on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.